This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Natera, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Hsin-Ta Wu: Innovator in Cancer Detection Technologies
Introduction
Hsin-Ta Wu is a prominent inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of cancer detection and monitoring. With a total of 2 patents, his work focuses on innovative methods that enhance the early detection of various cancers.
Latest Patents
Hsin-Ta Wu's latest patents revolve around methods for cancer detection and monitoring. These inventions provide techniques for detecting single nucleotide variants in breast cancer, bladder cancer, and colorectal cancer. The methods include generating a set of amplicons through multiplex amplification reactions on nucleic acids isolated from blood or urine samples. This process allows for the identification of patient-specific single nucleotide variants, which can indicate early relapse or metastasis of the cancers mentioned.
Career Highlights
Hsin-Ta Wu is currently associated with Natera, Inc., where he continues to develop groundbreaking technologies in the medical field. His work is crucial in improving cancer diagnostics and patient outcomes.
Collaborations
Some of his notable coworkers include Bernhard Zimmermann and Raheleh Salari, who contribute to the innovative environment at Natera, Inc.
Conclusion
Hsin-Ta Wu's contributions to cancer detection technologies exemplify the impact of innovation in healthcare. His patents are paving the way for more effective monitoring and treatment of cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile